Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Entecavir (0.05mg) Syrup
Therapeutic Category
Antiviral
Dosage Form
Syrup
Packaging Type
Bottle
Packaging
60 ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Viraent Syrup containing Entecavir is used for the management of chronic hepatitis B virus (HBV) infection. It helps suppress viral replication and supports long-term liver health under medical supervision.
Entecavir works as a nucleoside analogue antiviral agent that inhibits hepatitis B virus replication, helping reduce viral activity and supporting better clinical outcomes in patients with chronic HBV infection.
The syrup formulation is widely prescribed in hepatology, gastroenterology, and infectious disease practice, particularly for patients requiring convenient oral antiviral therapy, leading to consistent prescription demand.
With the increasing awareness of liver health and growing demand for effective antiviral therapies, this product offers strong business potential for retailers and distributors. Its established antiviral efficacy, clinical relevance, and steady market demand make it a reliable product for growth in the hepatitis care segment.
Some patients may experience headache, fatigue, dizziness, nausea, vomiting, diarrhea, abdominal discomfort, or difficulty sleeping. Rarely, severe liver-related reactions, allergic reactions, or lactic acidosis may occur and require immediate medical attention.
Viraent Syrup is indicated for the treatment of chronic Hepatitis B infection in adults and pediatric patients as prescribed by a healthcare professional. It helps suppress viral replication, improve liver enzyme levels, and reduce the risk of complications such as cirrhosis and liver failure associated with chronic HBV infection.
This medicine should be used strictly under medical supervision. Regular monitoring of liver function, kidney function, and viral load is recommended during treatment. Do not discontinue therapy without consulting a healthcare professional, as stopping treatment may lead to severe worsening of hepatitis B. Use cautiously in patients with kidney impairment or advanced liver disease. Follow the prescribed dosage and duration carefully for optimal therapeutic outcomes.
Store in a cool, dry place below 25°C, protected from direct sunlight and moisture. Keep the bottle tightly closed and out of reach of children. Use the syrup as directed and follow any storage instructions provided on the product packaging.
Composition : Doxofylline (400mg) + Ambroxol (30mg)
Composition : Doxofylline (400mg) + Montelukast (10mg)
Composition : Doxofylline (650mg) SR
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Tiotropium (9mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.